부산대학교 도서관

Leoni, M.; Musio, S.; Croci, M.; Amaducci, S.; Tang, K.; Magagnini, G.M.; Thouminot, C.; Müssig, J.

In: Industrial Crops and Products. (Industrial Crops and Products, 15 November 2022, 188)

Sobacchi, C.; Vezzoni, P.; Reid, D. M.; McGuigan, F. E. A.; Frattini, A.; Mirolo, M.; Albhaga, O. M. E.; Musio, A.; Villa, A.; Ralston, S. H.

Calcified Tissue International. January 2004 74(1):35-41

Taddei-Ferretti, C.; Musio, C.; Santillo, S.

Il Nuovo Cimento D. July 1995 17(7-8):941-947

S. Bellissimo; F. Iannone; A. Musio; M. Covelli; G. Lapadula

Reumatismo, Vol 53, Iss 3 (2001)

Gabrion, X.; Placet, V.; Koolen, G.; Van Vuure, A.; Grégoire, M.; Bar, M.; de Luycker, E.; Ouagne, P.; Musio, S.; Amaducci, S.; Botturi, D.; Rondi, G.

In: Composites Part A: Applied Science and Manufacturing. (Composites Part A: Applied Science and Manufacturing, June 2022, 157)

Sacco, M. G.; Faggioli, F.; Soldati, S.; Gribaldo, L.; Collotta, A.; Pariselli, F.; Malerba, I.; Musio, A.; Montagna, C.; Catò, E. Mira; Vezzoni, P.

Cell Proliferation. Dec 01, 2006 39(6):611-622

Musio, C.; Santillo, S.; Taddei-Ferretti, C.; Robles, L.J.; Vismara, R.; Barsanti, L.; Gualtieri, P.

Journal of Comparative Physiology A: Sensory, Neural and Behavioral Physiology. February 2001 187(1):79-81

Di Ianni N; Unit of Immunotherapy of Brain Tumors, Department of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133 Milan, Italy.; Musio S; Unit of Immunotherapy of Brain Tumors, Department of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133 Milan, Italy.; Pellegatta S; Unit of Immunotherapy of Brain Tumors, Department of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133 Milan, Italy.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Landoni E; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Fucá G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Wang J; Departments of Pharmacology and Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.; Chirasani VR; Departments of Pharmacology and Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.; Yao Z; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Dukhovlinova E; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Savoldo B; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Hong LK; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Shou P; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Musio S; Laboratory of Immunotherapy of Brain Tumors, Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.; Padelli F; Experimental Imaging and Neuro-Radiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.; Finocchiaro G; Laboratory of Immunotherapy of Brain Tumors, Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.; Droste M; Cell Medica Switzerland AG, Zurich-Schlieren, Switzerland.; Kuhlman B; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Shamshiev A; Cell Medica Switzerland AG, Zurich-Schlieren, Switzerland.; Pellegatta S; Laboratory of Immunotherapy of Brain Tumors, Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.; Dokholyan NV; Departments of Pharmacology and Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.; Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. gdotti@med.unc.edu.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

BRAUNER, E.; MUSIO, D.; MEZI, S.; CIOLFI, A.; MAGHELLA, F.; CASSONI, A.; DE ANGELIS, F.; GUARINO, G.; ROMEO, U.; TENORE, G.; PIESCO, G.; DE FELICE, F.; TOMBOLINI, V.; VALENTINI, V.; POLIMENI, A.; DI CARLO, S.

European Review for Medical & Pharmacological Sciences; 2019, Vol. 23 Issue 22, p9923-9930, 8p